Biomarkers are measurable indicators of a biological state. As our understanding of diseases meliorates, it is generally accepted that early diagnosis renders the best chance to cure a disease. In the context of proteomics, the discovery phase of identifying bonafide biomarkers and the ensuing validation phase involving large cohort of patient samples are impeded by…
PROTEOMICS - CLINICAL APPLICATIONS Template
Write in a clean editor, then format for PROTEOMICS - CLINICAL APPLICATIONS in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the PROTEOMICS - CLINICAL APPLICATIONS format
PROTEOMICS - CLINICAL APPLICATIONS is a peer-reviewed journal published by Wiley, covering Advanced Proteomics Techniques and Applications, Mass Spectrometry Techniques and Applications, Advanced Biosensing Techniques and Applications.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." PROTEOMICS - CLINICAL APPLICATIONS 12 (3): 45–58.
Formats any DOI in PROTEOMICS - CLINICAL APPLICATIONS style. No sign-up. |
| Publishes research in | Advanced Proteomics Techniques and Applications Mass Spectrometry Techniques and Applications Advanced Biosensing Techniques and Applications Biotin and Related Studies Glycosylation and Glycoproteins Research |
| ISSN | 1862-8346 |
| Citation impact (2-yr) | 2.23 |
| h-index | 76 |
| i10-index | 1,013 |
| Total citations | 40,294 |
| Article processing charge | $4,020 |
| Top institutions publishing here | Johns Hopkins University |
| Journal website | onlinelibrary.wiley.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in PROTEOMICS - CLINICAL APPLICATIONS per year
Citation impact of PROTEOMICS - CLINICAL APPLICATIONS by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in PROTEOMICS - CLINICAL APPLICATIONS
Oligodendrocytes synthesize the CNS myelin sheath by enwrapping axonal segments with elongations of their plasma membrane. Spatial and temporal control of membrane traffic is a prerequisite for proper myelin formation. The major myelin proteolipid protein (PLP) accumulates in late endosomal storage compartments and multivesicular bodies (MVBs). Fusion of MVBs with the plasma membrane results in…
Fibroblast activation protein (FAP) is best known for its heightened expression in tumour stroma. This atypical serine protease has both dipeptidyl peptidase and endopeptidase activities, cleaving substrates at a post-proline bond. FAP expression is difficult to detect in non-diseased adult organs, but is greatly upregulated in sites of tissue remodelling, which include liver fibrosis, lung…
Multiplex immunoassays confer several advantages over widely adopted singleplex immunoassays including increased efficiency at a reduced expense, greater output per sample volume ratios and higher throughput predicating more resolute, detailed diagnostics and facilitating personalised medicine. Nonetheless, to date, relatively few protein multiplex immunoassays have been validated for in vitro diagnostics in clinical/point-of-care settings. This review…
Democratization of genomics technologies has enabled the rapid determination of genotypes. More recently the democratization of comprehensive proteomics technologies is enabling the determination of the cellular phenotype and the molecular events that define its dynamic state. Core proteomic technologies include MS to define protein sequence, protein:protein interactions, and protein PTMs. Key enabling technologies for proteomics…